William R. Jarnagin

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

136h-index71.7kcitations1.1kworks4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies(429), Pancreatic and Hepatic Oncology Research(381), Hepatocellular Carcinoma Treatment and Prognosis(371), Gallbladder and Bile Duct Disorders(160), Colorectal Cancer Treatments and Studies(145)

Publications1.1k total

Evaluating the prognostic impact of IDH mutations in intrahepatic cholangiocarcinoma.
Journal of Clinical Oncology·2026
Genome-based classification of pancreatic acinar cell carcinoma reveals similarities to KRAS wild-type PDAC
Journal of Translational Medicine·2025Open Access
Postoperative Pancreatic Fistula After Pancreatoduodenectomy
Annals of Surgery·2025
Figure s2 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Figure S1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
supplementary legend1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
Supplementary Data1 from Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
2025Open Access
ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma
Annals of Surgical Oncology·2025
ASO Visual Abstract: Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases
Annals of Surgical Oncology·2025
Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases
Annals of Surgical Oncology·2025
Multimodal machine learning models enhance outcome prediction in intrahepatic cholangiocarcinoma
Computers in Biology and Medicine·2025
One-Year Mortality after Hepatectomy: Defining a Novel Quality Metric
Annals of Surgical Oncology·2025· 1 cited
Outcomes of First Versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma
Annals of Surgical Oncology·2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and Survival
JCO Precision Oncology·2025
A Novel Predictive Model for Cancer-Specific Surgical Risk Stratification of Patients Undergoing High-Risk Upper Gastrointestinal Oncologic Resections
Annals of Surgery·2025
Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma
Cancer·2025· 1 citedOpen Access
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
2025· 1 citedOpen Access
ASO Visual Abstract: One-Year Mortality after Hepatectomy: Defining a Novel Quality Metric
Annals of Surgical Oncology·2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer
JCO Precision Oncology·2025· 2 citedOpen Access
Long-Term Outcomes of Patients Undergoing Two-Stage Hepatectomy For Extensive Colorectal Liver Metastasis Treated With Perioperative Hepatic Artery and Systemic Chemotherapy
Annals of Surgery·2025
page 1 of 55Next →

Frequent Co-authors

Yuman Fong(32), Ronald P. DeMatteo(28), Leslie H. Blumgart(26), Mithat Gönen(17), Michael I. D’Angelica(10), Michael I. D’Angelica(10), David S. Klimstra(9), Peter J. Allen(9), Nancy E. Kemeny(6), Murray F. Brennan(6), Ghassan K. Abou‐Alfa(6), Richard Kinh Gian(5), Eileen M. O’Reilly(5), T. Peter Kingham(4), Lawrence H. Schwartz(4), Leah Ben‐Porat(3), Sarah Little(3), Carlos U. Corvera(3), H. Wéber(3), Karen T. Brown(3)